Related Experiment Video

Updated: Feb 21, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K

Lung Cancer Heterogeneity and New Strategies for Drug Therapy

Diane C Wang1, William Wang1, Bijun Zhu1

  • 1Zhongshan Hospital Institute of Clinical Science, Shanghai Institute of Clinical Bioinformatics, Fudan University Center for Clinical Bioinformatics, Shanghai 200032, China;

Annual Review of Pharmacology and Toxicology
|October 5, 2017
PubMed

Insights

Lung cancer heterogeneity drives drug resistance. A precise self-validation system using gene sequencing and patient-derived models improves targeted therapy selection for personalized lung cancer treatment.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacology

Background:

  • Lung cancer heterogeneity is a key factor in acquired drug resistance.
  • Understanding genetic alterations, including hereditary and somatic mutations, is crucial for effective treatment.

Purpose of the Study:

  • To explore the role of specific genes (PIK3CD, TP53, KRAS) in lung cancer heterogeneity.
  • To introduce a precise self-validation system for selecting targeted therapies.
  • To enhance the precision of cancer treatment through improved validation strategies.

Main Methods:

  • Comprehensive molecular characterization of lung cancer.
  • Gene sequencing for identifying mutations and heterogeneity.
  • Validation of therapeutic strategies in patient-derived xenografts or cancer cells.
  • Protein structure-guided compound screening and DNA-encoded chemical libraries for drug selection.

Main Results:

  • Characterization of heterogeneity specificity, and roles of PIK3CD, TP53, and KRAS.
  • Demonstration of a self-validation system for personalized treatment strategies.
  • Potential for increased precision in therapeutic outcomes through advanced drug screening and validation.

Conclusions:

  • A deeper understanding of lung cancer heterogeneity mechanisms is essential.
  • Improved validation of therapeutic strategies leads to more precise and effective patient treatments.
  • The proposed self-validation system offers a pathway to personalized medicine in lung cancer therapy.
Keywords:
gene mutationsheterogeneitylung cancertarget drugstherapeutic strategy

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

454

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K